Torch Technologies News

Torch Technologies Digital Journal / May 4, 2022

The latest market research report analyzes the Marine Battery market demand by different segments Si

Torch Technologies Digital Journal / May 4, 2022

New details of our past are coming to light, hiding in the nooks and crannies of the world, as we refine our techniques to go looking for them. Most lauded is the reconstruction of the evolution of humanity since our African origins around 300,000 years ago, by analyzing our living and fossil DNA. R…

Torch Technologies Digital Journal / May 4, 2022

Submarine Battery Market- increasing demand with Industry Professionals: EnerSys Systems Sunlight SA, Exide Technologies, Zibo Torch Energy Co., Ltd., etc – ManufactureLink  ManufactureLink

Torch Technologies Digital Journal / May 4, 2022

“Hand Soldering”Market 2022 with a CAGR of CAGR of xx% - Impact of COVID-19 on the Market: The report contains financial data achieve from

Torch Technologies Fierce Biotech / May 2, 2022

By Stefan Merlo, Seqirus Vice President Commercial Development | Stefan Merlo, Vice President of Commercial Development at Seqirus, shares in-depth commentary on the recent innovation renaissance in influenza vaccine technology and what it means for public health.

Torch Technologies Fierce Biotech / May 2, 2022

Dollar signs aren’t the only green thing at Breakthrough Properties. | Dollar signs aren’t the only green thing at Breakthrough Properties. A joint venture of biotech investment firm Bellco Capital and real estate developer and investor Tishman Speyer, Breakthrough’s $3 billion fund will go to buyin…

Torch Technologies Fierce Biotech / May 2, 2022

The blood-testing company Guardant Health aims to offer a simpler option to people who may have missed their recommended appointments to be checked out for colorectal cancer—such as a colonoscopy—w | The blood-testing company Guardant Health aims to offer a simpler option to people who may have miss…

Torch Technologies Fierce Biotech / May 2, 2022

Dragonfly Therapeutics’ TriNKET platform seems to be turning out more than simple tchotchkes, if buy-ins from Merck & Co., AbbVie and Bristol Myers Squibb are any indication. | Gilead has become the latest Big Pharma to find a gem from Dragonfly Therapeutics, entering a $300 million upfront deal to…

Torch Technologies Fierce Biotech / May 2, 2022

Tarsus Pharmaceuticals says mites are no match for its novel eye drop, posting positive phase 3 data that the company intends to ride all the way to regulators later this year. | Tarsus Pharmaceuticals says mites are no match for its novel eye drop, posting positive phase 3 data that the company in…